nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Topotecan—ovarian cancer	0.0673	0.354	CbGbCtD
Salbutamol—CYP3A4—Vinorelbine—ovarian cancer	0.0474	0.25	CbGbCtD
Salbutamol—CYP3A4—Paclitaxel—ovarian cancer	0.0333	0.175	CbGbCtD
Salbutamol—CYP3A4—Docetaxel—ovarian cancer	0.0241	0.127	CbGbCtD
Salbutamol—CYP3A4—Doxorubicin—ovarian cancer	0.018	0.0945	CbGbCtD
Salbutamol—Isoprenaline—MAPK1—ovarian cancer	0.00758	0.809	CrCbGaD
Salbutamol—Nadolol—ABCB1—ovarian cancer	0.00179	0.191	CrCbGaD
Salbutamol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000656	0.00082	CcSEcCtD
Salbutamol—Headache—Vinorelbine—ovarian cancer	0.000654	0.000817	CcSEcCtD
Salbutamol—Syncope—Docetaxel—ovarian cancer	0.000654	0.000817	CcSEcCtD
Salbutamol—Asthma—Doxorubicin—ovarian cancer	0.000653	0.000816	CcSEcCtD
Salbutamol—Influenza—Doxorubicin—ovarian cancer	0.000653	0.000816	CcSEcCtD
Salbutamol—Palpitations—Docetaxel—ovarian cancer	0.000645	0.000805	CcSEcCtD
Salbutamol—Loss of consciousness—Docetaxel—ovarian cancer	0.000641	0.000801	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00064	0.000799	CcSEcCtD
Salbutamol—Hyperglycaemia—Epirubicin—ovarian cancer	0.000637	0.000796	CcSEcCtD
Salbutamol—Cough—Docetaxel—ovarian cancer	0.000637	0.000795	CcSEcCtD
Salbutamol—Angina pectoris—Doxorubicin—ovarian cancer	0.000636	0.000795	CcSEcCtD
Salbutamol—Insomnia—Paclitaxel—ovarian cancer	0.000635	0.000794	CcSEcCtD
Salbutamol—Paraesthesia—Paclitaxel—ovarian cancer	0.000631	0.000788	CcSEcCtD
Salbutamol—Hypertension—Docetaxel—ovarian cancer	0.00063	0.000787	CcSEcCtD
Salbutamol—Drowsiness—Epirubicin—ovarian cancer	0.00063	0.000786	CcSEcCtD
Salbutamol—Bronchitis—Doxorubicin—ovarian cancer	0.000628	0.000785	CcSEcCtD
Salbutamol—Dyspnoea—Paclitaxel—ovarian cancer	0.000626	0.000782	CcSEcCtD
Salbutamol—Somnolence—Paclitaxel—ovarian cancer	0.000624	0.00078	CcSEcCtD
Salbutamol—Chest pain—Docetaxel—ovarian cancer	0.000621	0.000776	CcSEcCtD
Salbutamol—Myalgia—Docetaxel—ovarian cancer	0.000621	0.000776	CcSEcCtD
Salbutamol—Arthralgia—Docetaxel—ovarian cancer	0.000621	0.000776	CcSEcCtD
Salbutamol—Nausea—Vinorelbine—ovarian cancer	0.00062	0.000775	CcSEcCtD
Salbutamol—Dyspepsia—Paclitaxel—ovarian cancer	0.000618	0.000772	CcSEcCtD
Salbutamol—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000617	0.000771	CcSEcCtD
Salbutamol—Stomatitis—Epirubicin—ovarian cancer	0.000614	0.000767	CcSEcCtD
Salbutamol—Jaundice—Epirubicin—ovarian cancer	0.000614	0.000767	CcSEcCtD
Salbutamol—Urinary tract infection—Epirubicin—ovarian cancer	0.000612	0.000764	CcSEcCtD
Salbutamol—Conjunctivitis—Epirubicin—ovarian cancer	0.000612	0.000764	CcSEcCtD
Salbutamol—Dysuria—Doxorubicin—ovarian cancer	0.000611	0.000763	CcSEcCtD
Salbutamol—Decreased appetite—Paclitaxel—ovarian cancer	0.000611	0.000763	CcSEcCtD
Salbutamol—Dry mouth—Docetaxel—ovarian cancer	0.000607	0.000759	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000607	0.000759	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000606	0.000757	CcSEcCtD
Salbutamol—Fatigue—Paclitaxel—ovarian cancer	0.000606	0.000756	CcSEcCtD
Salbutamol—Sweating—Epirubicin—ovarian cancer	0.000604	0.000754	CcSEcCtD
Salbutamol—Constipation—Paclitaxel—ovarian cancer	0.000601	0.00075	CcSEcCtD
Salbutamol—Pain—Paclitaxel—ovarian cancer	0.000601	0.00075	CcSEcCtD
Salbutamol—Haematuria—Epirubicin—ovarian cancer	0.0006	0.00075	CcSEcCtD
Salbutamol—Oedema—Docetaxel—ovarian cancer	0.000595	0.000744	CcSEcCtD
Salbutamol—Anaphylactic shock—Docetaxel—ovarian cancer	0.000595	0.000744	CcSEcCtD
Salbutamol—Epistaxis—Epirubicin—ovarian cancer	0.000594	0.000742	CcSEcCtD
Salbutamol—Infection—Docetaxel—ovarian cancer	0.000591	0.000739	CcSEcCtD
Salbutamol—Sinusitis—Epirubicin—ovarian cancer	0.000591	0.000738	CcSEcCtD
Salbutamol—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000589	0.000736	CcSEcCtD
Salbutamol—Shock—Docetaxel—ovarian cancer	0.000586	0.000732	CcSEcCtD
Salbutamol—Nervous system disorder—Docetaxel—ovarian cancer	0.000584	0.000729	CcSEcCtD
Salbutamol—Drowsiness—Doxorubicin—ovarian cancer	0.000583	0.000728	CcSEcCtD
Salbutamol—Tachycardia—Docetaxel—ovarian cancer	0.000581	0.000726	CcSEcCtD
Salbutamol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000579	0.000723	CcSEcCtD
Salbutamol—Skin disorder—Docetaxel—ovarian cancer	0.000578	0.000722	CcSEcCtD
Salbutamol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000574	0.000717	CcSEcCtD
Salbutamol—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000571	0.000713	CcSEcCtD
Salbutamol—Haemoglobin—Epirubicin—ovarian cancer	0.000568	0.00071	CcSEcCtD
Salbutamol—Jaundice—Doxorubicin—ovarian cancer	0.000568	0.000709	CcSEcCtD
Salbutamol—Stomatitis—Doxorubicin—ovarian cancer	0.000568	0.000709	CcSEcCtD
Salbutamol—Anorexia—Docetaxel—ovarian cancer	0.000568	0.000709	CcSEcCtD
Salbutamol—Rhinitis—Epirubicin—ovarian cancer	0.000567	0.000708	CcSEcCtD
Salbutamol—Urinary tract infection—Doxorubicin—ovarian cancer	0.000566	0.000707	CcSEcCtD
Salbutamol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000566	0.000707	CcSEcCtD
Salbutamol—Haemorrhage—Epirubicin—ovarian cancer	0.000565	0.000706	CcSEcCtD
Salbutamol—Hypoaesthesia—Epirubicin—ovarian cancer	0.000562	0.000702	CcSEcCtD
Salbutamol—Pharyngitis—Epirubicin—ovarian cancer	0.000561	0.000701	CcSEcCtD
Salbutamol—Sweating—Doxorubicin—ovarian cancer	0.000559	0.000698	CcSEcCtD
Salbutamol—Urinary tract disorder—Epirubicin—ovarian cancer	0.000558	0.000697	CcSEcCtD
Salbutamol—Urticaria—Paclitaxel—ovarian cancer	0.000558	0.000697	CcSEcCtD
Salbutamol—Hypotension—Docetaxel—ovarian cancer	0.000556	0.000695	CcSEcCtD
Salbutamol—Haematuria—Doxorubicin—ovarian cancer	0.000555	0.000694	CcSEcCtD
Salbutamol—Connective tissue disorder—Epirubicin—ovarian cancer	0.000555	0.000694	CcSEcCtD
Salbutamol—Body temperature increased—Paclitaxel—ovarian cancer	0.000555	0.000694	CcSEcCtD
Salbutamol—Abdominal pain—Paclitaxel—ovarian cancer	0.000555	0.000694	CcSEcCtD
Salbutamol—Urethral disorder—Epirubicin—ovarian cancer	0.000554	0.000692	CcSEcCtD
Salbutamol—Epistaxis—Doxorubicin—ovarian cancer	0.00055	0.000686	CcSEcCtD
Salbutamol—Sinusitis—Doxorubicin—ovarian cancer	0.000547	0.000683	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000542	0.000678	CcSEcCtD
Salbutamol—Insomnia—Docetaxel—ovarian cancer	0.000538	0.000673	CcSEcCtD
Salbutamol—Paraesthesia—Docetaxel—ovarian cancer	0.000535	0.000668	CcSEcCtD
Salbutamol—Dyspnoea—Docetaxel—ovarian cancer	0.000531	0.000663	CcSEcCtD
Salbutamol—Somnolence—Docetaxel—ovarian cancer	0.000529	0.000661	CcSEcCtD
Salbutamol—Tinnitus—Epirubicin—ovarian cancer	0.000527	0.000658	CcSEcCtD
Salbutamol—Haemoglobin—Doxorubicin—ovarian cancer	0.000526	0.000657	CcSEcCtD
Salbutamol—Cardiac disorder—Epirubicin—ovarian cancer	0.000525	0.000655	CcSEcCtD
Salbutamol—Flushing—Epirubicin—ovarian cancer	0.000525	0.000655	CcSEcCtD
Salbutamol—Rhinitis—Doxorubicin—ovarian cancer	0.000524	0.000655	CcSEcCtD
Salbutamol—Dyspepsia—Docetaxel—ovarian cancer	0.000524	0.000655	CcSEcCtD
Salbutamol—Haemorrhage—Doxorubicin—ovarian cancer	0.000523	0.000653	CcSEcCtD
Salbutamol—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00052	0.00065	CcSEcCtD
Salbutamol—Pharyngitis—Doxorubicin—ovarian cancer	0.000519	0.000648	CcSEcCtD
Salbutamol—Decreased appetite—Docetaxel—ovarian cancer	0.000518	0.000646	CcSEcCtD
Salbutamol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000518	0.000646	CcSEcCtD
Salbutamol—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000516	0.000645	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000514	0.000642	CcSEcCtD
Salbutamol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000514	0.000642	CcSEcCtD
Salbutamol—Fatigue—Docetaxel—ovarian cancer	0.000513	0.000641	CcSEcCtD
Salbutamol—Angiopathy—Epirubicin—ovarian cancer	0.000513	0.000641	CcSEcCtD
Salbutamol—Urethral disorder—Doxorubicin—ovarian cancer	0.000513	0.00064	CcSEcCtD
Salbutamol—Immune system disorder—Epirubicin—ovarian cancer	0.000511	0.000638	CcSEcCtD
Salbutamol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000509	0.000636	CcSEcCtD
Salbutamol—Constipation—Docetaxel—ovarian cancer	0.000509	0.000636	CcSEcCtD
Salbutamol—Pain—Docetaxel—ovarian cancer	0.000509	0.000636	CcSEcCtD
Salbutamol—Chills—Epirubicin—ovarian cancer	0.000507	0.000633	CcSEcCtD
Salbutamol—Arrhythmia—Epirubicin—ovarian cancer	0.000505	0.000631	CcSEcCtD
Salbutamol—Asthenia—Paclitaxel—ovarian cancer	0.000504	0.000629	CcSEcCtD
Salbutamol—Pruritus—Paclitaxel—ovarian cancer	0.000497	0.000621	CcSEcCtD
Salbutamol—Mental disorder—Epirubicin—ovarian cancer	0.000495	0.000619	CcSEcCtD
Salbutamol—Malnutrition—Epirubicin—ovarian cancer	0.000492	0.000615	CcSEcCtD
Salbutamol—Feeling abnormal—Docetaxel—ovarian cancer	0.000491	0.000613	CcSEcCtD
Salbutamol—Tinnitus—Doxorubicin—ovarian cancer	0.000488	0.000609	CcSEcCtD
Salbutamol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000487	0.000608	CcSEcCtD
Salbutamol—Cardiac disorder—Doxorubicin—ovarian cancer	0.000485	0.000606	CcSEcCtD
Salbutamol—Flushing—Doxorubicin—ovarian cancer	0.000485	0.000606	CcSEcCtD
Salbutamol—Flatulence—Epirubicin—ovarian cancer	0.000485	0.000606	CcSEcCtD
Salbutamol—Tension—Epirubicin—ovarian cancer	0.000483	0.000603	CcSEcCtD
Salbutamol—Dysgeusia—Epirubicin—ovarian cancer	0.000482	0.000602	CcSEcCtD
Salbutamol—Diarrhoea—Paclitaxel—ovarian cancer	0.000481	0.0006	CcSEcCtD
Salbutamol—Nervousness—Epirubicin—ovarian cancer	0.000478	0.000597	CcSEcCtD
Salbutamol—Back pain—Epirubicin—ovarian cancer	0.000476	0.000595	CcSEcCtD
Salbutamol—Angiopathy—Doxorubicin—ovarian cancer	0.000475	0.000593	CcSEcCtD
Salbutamol—Muscle spasms—Epirubicin—ovarian cancer	0.000473	0.000591	CcSEcCtD
Salbutamol—Immune system disorder—Doxorubicin—ovarian cancer	0.000472	0.00059	CcSEcCtD
Salbutamol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000471	0.000589	CcSEcCtD
Salbutamol—Body temperature increased—Docetaxel—ovarian cancer	0.000471	0.000588	CcSEcCtD
Salbutamol—Abdominal pain—Docetaxel—ovarian cancer	0.000471	0.000588	CcSEcCtD
Salbutamol—Chills—Doxorubicin—ovarian cancer	0.000469	0.000586	CcSEcCtD
Salbutamol—Arrhythmia—Doxorubicin—ovarian cancer	0.000467	0.000584	CcSEcCtD
Salbutamol—Dizziness—Paclitaxel—ovarian cancer	0.000464	0.00058	CcSEcCtD
Salbutamol—Mental disorder—Doxorubicin—ovarian cancer	0.000458	0.000572	CcSEcCtD
Salbutamol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000457	0.00057	CcSEcCtD
Salbutamol—Malnutrition—Doxorubicin—ovarian cancer	0.000455	0.000569	CcSEcCtD
Salbutamol—Agitation—Epirubicin—ovarian cancer	0.000452	0.000565	CcSEcCtD
Salbutamol—Flatulence—Doxorubicin—ovarian cancer	0.000449	0.00056	CcSEcCtD
Salbutamol—Tension—Doxorubicin—ovarian cancer	0.000447	0.000558	CcSEcCtD
Salbutamol—Vomiting—Paclitaxel—ovarian cancer	0.000447	0.000558	CcSEcCtD
Salbutamol—Dysgeusia—Doxorubicin—ovarian cancer	0.000446	0.000557	CcSEcCtD
Salbutamol—Malaise—Epirubicin—ovarian cancer	0.000444	0.000554	CcSEcCtD
Salbutamol—Rash—Paclitaxel—ovarian cancer	0.000443	0.000553	CcSEcCtD
Salbutamol—Dermatitis—Paclitaxel—ovarian cancer	0.000442	0.000553	CcSEcCtD
Salbutamol—Nervousness—Doxorubicin—ovarian cancer	0.000442	0.000552	CcSEcCtD
Salbutamol—Vertigo—Epirubicin—ovarian cancer	0.000442	0.000552	CcSEcCtD
Salbutamol—Syncope—Epirubicin—ovarian cancer	0.000441	0.000551	CcSEcCtD
Salbutamol—Back pain—Doxorubicin—ovarian cancer	0.00044	0.00055	CcSEcCtD
Salbutamol—Headache—Paclitaxel—ovarian cancer	0.00044	0.00055	CcSEcCtD
Salbutamol—Hypersensitivity—Docetaxel—ovarian cancer	0.000439	0.000548	CcSEcCtD
Salbutamol—Muscle spasms—Doxorubicin—ovarian cancer	0.000438	0.000547	CcSEcCtD
Salbutamol—Palpitations—Epirubicin—ovarian cancer	0.000435	0.000543	CcSEcCtD
Salbutamol—Loss of consciousness—Epirubicin—ovarian cancer	0.000432	0.00054	CcSEcCtD
Salbutamol—Cough—Epirubicin—ovarian cancer	0.000429	0.000536	CcSEcCtD
Salbutamol—Asthenia—Docetaxel—ovarian cancer	0.000427	0.000534	CcSEcCtD
Salbutamol—Hypertension—Epirubicin—ovarian cancer	0.000425	0.000531	CcSEcCtD
Salbutamol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000422	0.000528	CcSEcCtD
Salbutamol—Pruritus—Docetaxel—ovarian cancer	0.000421	0.000526	CcSEcCtD
Salbutamol—Myalgia—Epirubicin—ovarian cancer	0.000419	0.000523	CcSEcCtD
Salbutamol—Arthralgia—Epirubicin—ovarian cancer	0.000419	0.000523	CcSEcCtD
Salbutamol—Chest pain—Epirubicin—ovarian cancer	0.000419	0.000523	CcSEcCtD
Salbutamol—Agitation—Doxorubicin—ovarian cancer	0.000418	0.000523	CcSEcCtD
Salbutamol—Anxiety—Epirubicin—ovarian cancer	0.000417	0.000521	CcSEcCtD
Salbutamol—Nausea—Paclitaxel—ovarian cancer	0.000417	0.000521	CcSEcCtD
Salbutamol—Discomfort—Epirubicin—ovarian cancer	0.000414	0.000517	CcSEcCtD
Salbutamol—Malaise—Doxorubicin—ovarian cancer	0.000411	0.000513	CcSEcCtD
Salbutamol—Dry mouth—Epirubicin—ovarian cancer	0.00041	0.000512	CcSEcCtD
Salbutamol—Vertigo—Doxorubicin—ovarian cancer	0.000409	0.000511	CcSEcCtD
Salbutamol—Syncope—Doxorubicin—ovarian cancer	0.000408	0.00051	CcSEcCtD
Salbutamol—Diarrhoea—Docetaxel—ovarian cancer	0.000407	0.000509	CcSEcCtD
Salbutamol—Palpitations—Doxorubicin—ovarian cancer	0.000402	0.000503	CcSEcCtD
Salbutamol—Oedema—Epirubicin—ovarian cancer	0.000402	0.000502	CcSEcCtD
Salbutamol—Anaphylactic shock—Epirubicin—ovarian cancer	0.000402	0.000502	CcSEcCtD
Salbutamol—Loss of consciousness—Doxorubicin—ovarian cancer	0.0004	0.0005	CcSEcCtD
Salbutamol—Infection—Epirubicin—ovarian cancer	0.000399	0.000498	CcSEcCtD
Salbutamol—Cough—Doxorubicin—ovarian cancer	0.000397	0.000496	CcSEcCtD
Salbutamol—Shock—Epirubicin—ovarian cancer	0.000395	0.000493	CcSEcCtD
Salbutamol—Nervous system disorder—Epirubicin—ovarian cancer	0.000394	0.000492	CcSEcCtD
Salbutamol—Dizziness—Docetaxel—ovarian cancer	0.000394	0.000492	CcSEcCtD
Salbutamol—Hypertension—Doxorubicin—ovarian cancer	0.000393	0.000491	CcSEcCtD
Salbutamol—Tachycardia—Epirubicin—ovarian cancer	0.000392	0.00049	CcSEcCtD
Salbutamol—Skin disorder—Epirubicin—ovarian cancer	0.00039	0.000487	CcSEcCtD
Salbutamol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000388	0.000485	CcSEcCtD
Salbutamol—Arthralgia—Doxorubicin—ovarian cancer	0.000388	0.000484	CcSEcCtD
Salbutamol—Myalgia—Doxorubicin—ovarian cancer	0.000388	0.000484	CcSEcCtD
Salbutamol—Chest pain—Doxorubicin—ovarian cancer	0.000388	0.000484	CcSEcCtD
Salbutamol—Anxiety—Doxorubicin—ovarian cancer	0.000386	0.000482	CcSEcCtD
Salbutamol—Discomfort—Doxorubicin—ovarian cancer	0.000383	0.000478	CcSEcCtD
Salbutamol—Anorexia—Epirubicin—ovarian cancer	0.000383	0.000478	CcSEcCtD
Salbutamol—Dry mouth—Doxorubicin—ovarian cancer	0.000379	0.000473	CcSEcCtD
Salbutamol—Vomiting—Docetaxel—ovarian cancer	0.000379	0.000473	CcSEcCtD
Salbutamol—Rash—Docetaxel—ovarian cancer	0.000375	0.000469	CcSEcCtD
Salbutamol—Hypotension—Epirubicin—ovarian cancer	0.000375	0.000469	CcSEcCtD
Salbutamol—Dermatitis—Docetaxel—ovarian cancer	0.000375	0.000468	CcSEcCtD
Salbutamol—Headache—Docetaxel—ovarian cancer	0.000373	0.000466	CcSEcCtD
Salbutamol—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000372	0.000464	CcSEcCtD
Salbutamol—Oedema—Doxorubicin—ovarian cancer	0.000372	0.000464	CcSEcCtD
Salbutamol—Infection—Doxorubicin—ovarian cancer	0.000369	0.000461	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000366	0.000457	CcSEcCtD
Salbutamol—Shock—Doxorubicin—ovarian cancer	0.000366	0.000457	CcSEcCtD
Salbutamol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000364	0.000455	CcSEcCtD
Salbutamol—Insomnia—Epirubicin—ovarian cancer	0.000363	0.000454	CcSEcCtD
Salbutamol—Tachycardia—Doxorubicin—ovarian cancer	0.000363	0.000453	CcSEcCtD
Salbutamol—Skin disorder—Doxorubicin—ovarian cancer	0.000361	0.000451	CcSEcCtD
Salbutamol—Paraesthesia—Epirubicin—ovarian cancer	0.000361	0.00045	CcSEcCtD
Salbutamol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000359	0.000449	CcSEcCtD
Salbutamol—Dyspnoea—Epirubicin—ovarian cancer	0.000358	0.000447	CcSEcCtD
Salbutamol—Somnolence—Epirubicin—ovarian cancer	0.000357	0.000446	CcSEcCtD
Salbutamol—Anorexia—Doxorubicin—ovarian cancer	0.000354	0.000442	CcSEcCtD
Salbutamol—Nausea—Docetaxel—ovarian cancer	0.000354	0.000442	CcSEcCtD
Salbutamol—Dyspepsia—Epirubicin—ovarian cancer	0.000353	0.000442	CcSEcCtD
Salbutamol—Decreased appetite—Epirubicin—ovarian cancer	0.000349	0.000436	CcSEcCtD
Salbutamol—Hypotension—Doxorubicin—ovarian cancer	0.000347	0.000434	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000347	0.000433	CcSEcCtD
Salbutamol—Fatigue—Epirubicin—ovarian cancer	0.000346	0.000432	CcSEcCtD
Salbutamol—Constipation—Epirubicin—ovarian cancer	0.000343	0.000429	CcSEcCtD
Salbutamol—Pain—Epirubicin—ovarian cancer	0.000343	0.000429	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000339	0.000423	CcSEcCtD
Salbutamol—Insomnia—Doxorubicin—ovarian cancer	0.000336	0.00042	CcSEcCtD
Salbutamol—Paraesthesia—Doxorubicin—ovarian cancer	0.000334	0.000417	CcSEcCtD
Salbutamol—Dyspnoea—Doxorubicin—ovarian cancer	0.000331	0.000414	CcSEcCtD
Salbutamol—Feeling abnormal—Epirubicin—ovarian cancer	0.000331	0.000413	CcSEcCtD
Salbutamol—Somnolence—Doxorubicin—ovarian cancer	0.00033	0.000413	CcSEcCtD
Salbutamol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000328	0.00041	CcSEcCtD
Salbutamol—Dyspepsia—Doxorubicin—ovarian cancer	0.000327	0.000409	CcSEcCtD
Salbutamol—Decreased appetite—Doxorubicin—ovarian cancer	0.000323	0.000403	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000321	0.000401	CcSEcCtD
Salbutamol—Fatigue—Doxorubicin—ovarian cancer	0.00032	0.0004	CcSEcCtD
Salbutamol—Urticaria—Epirubicin—ovarian cancer	0.000319	0.000398	CcSEcCtD
Salbutamol—Pain—Doxorubicin—ovarian cancer	0.000318	0.000397	CcSEcCtD
Salbutamol—Constipation—Doxorubicin—ovarian cancer	0.000318	0.000397	CcSEcCtD
Salbutamol—Body temperature increased—Epirubicin—ovarian cancer	0.000317	0.000397	CcSEcCtD
Salbutamol—Abdominal pain—Epirubicin—ovarian cancer	0.000317	0.000397	CcSEcCtD
Salbutamol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000306	0.000382	CcSEcCtD
Salbutamol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000304	0.00038	CcSEcCtD
Salbutamol—Hypersensitivity—Epirubicin—ovarian cancer	0.000296	0.00037	CcSEcCtD
Salbutamol—Urticaria—Doxorubicin—ovarian cancer	0.000295	0.000369	CcSEcCtD
Salbutamol—Abdominal pain—Doxorubicin—ovarian cancer	0.000294	0.000367	CcSEcCtD
Salbutamol—Body temperature increased—Doxorubicin—ovarian cancer	0.000294	0.000367	CcSEcCtD
Salbutamol—Asthenia—Epirubicin—ovarian cancer	0.000288	0.00036	CcSEcCtD
Salbutamol—Pruritus—Epirubicin—ovarian cancer	0.000284	0.000355	CcSEcCtD
Salbutamol—Diarrhoea—Epirubicin—ovarian cancer	0.000275	0.000343	CcSEcCtD
Salbutamol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000274	0.000342	CcSEcCtD
Salbutamol—Asthenia—Doxorubicin—ovarian cancer	0.000267	0.000333	CcSEcCtD
Salbutamol—Dizziness—Epirubicin—ovarian cancer	0.000266	0.000332	CcSEcCtD
Salbutamol—Pruritus—Doxorubicin—ovarian cancer	0.000263	0.000328	CcSEcCtD
Salbutamol—Vomiting—Epirubicin—ovarian cancer	0.000255	0.000319	CcSEcCtD
Salbutamol—Diarrhoea—Doxorubicin—ovarian cancer	0.000254	0.000318	CcSEcCtD
Salbutamol—Rash—Epirubicin—ovarian cancer	0.000253	0.000316	CcSEcCtD
Salbutamol—Dermatitis—Epirubicin—ovarian cancer	0.000253	0.000316	CcSEcCtD
Salbutamol—Headache—Epirubicin—ovarian cancer	0.000252	0.000314	CcSEcCtD
Salbutamol—Dizziness—Doxorubicin—ovarian cancer	0.000246	0.000307	CcSEcCtD
Salbutamol—Nausea—Epirubicin—ovarian cancer	0.000239	0.000298	CcSEcCtD
Salbutamol—Vomiting—Doxorubicin—ovarian cancer	0.000236	0.000295	CcSEcCtD
Salbutamol—Rash—Doxorubicin—ovarian cancer	0.000234	0.000293	CcSEcCtD
Salbutamol—Dermatitis—Doxorubicin—ovarian cancer	0.000234	0.000292	CcSEcCtD
Salbutamol—Headache—Doxorubicin—ovarian cancer	0.000233	0.000291	CcSEcCtD
Salbutamol—Nausea—Doxorubicin—ovarian cancer	0.000221	0.000276	CcSEcCtD
